VOLUME 63   2002   NUMBER 10

Issue to be mailed October 22, 2002

CME Pretest 853

CME Posttest 954

Brainstorms

854 Independent Actions on Fear Circuits May Lead to Therapeutic Synergy for Anxiety When Combining Serotonergic and GABAergic Agents. Stephen M. Stahl
[PDF]

Original Articles

856 The Effects of Novel Antipsychotics on Glucose and Lipid Levels. Donna A. Wirshing, Jennifer A. Boyd, Laura R. Meng, Jacob S. Ballon, Stephen R. Marder, and William C. Wirshing
[Abstract] [PDF]

866 A Longitudinal View of Triggers and Thresholds of Suicidal Behavior in Depression. [CME] Lukas Pezawas, Mara Stamenkovic, Reinhold Jagsch, Sandra Ackerl, Christine Putz, Barbara Stelzer, Rebecca R. Moffat, Shird Schindler, Harald Aschauer, and Siegfried Kasper
[Abstract] [PDF]

874 Sexual Function and Behavior in Social Phobia. Liron Bodinger, Haggai Hermesh, Dov Aizenberg, Avi Valevski, Sofi Marom, Roni Shiloh, Doron Gothelf, Zvi Zemishlany, and Abraham Weizman
[Abstract] [PDF]

880 Clozapine-Induced Fevers and 1-Year Clozapine Discontinuation Rate. Joseph C. Tham and Ruth A. Dickson
[Abstract] [PDF]

885 Risperidone, 2 mg/day vs. 4 mg/day, in First-Episode, Acutely Psychotic Patients: Treatment Efficacy and Effects on Fine Motor Functioning. Marco C. G. Merlo, Helene Hofer, Walter Gekle, Gregor Berger, Joseph Ventura, Ingrid Panhuber, Gabriela Latour, and Stephen R. Marder
[Abstract] [PDF]

892 Prevalence of and Risk Factors for Medication Nonadherence in Patients With Schizophrenia: A Comprehensive Review of Recent Literature.  [CME] Jonathan P. Lacro, Laura B. Dunn, Christian R. Dolder, Susan G. Leckband, and Dilip V. Jeste
[Abstract] [PDF]

910 Serum Bupropion Levels in 2 Breastfeeding Mother-Infant Pairs. Susan W. Baab, Kathleen S. Peindl, Catherine M. Piontek, and Katherine L. Wisner
[Abstract] [PDF]

912 Personality Impairment in Male Pedophiles. Lisa J. Cohen, Pamela G. McGeoch, Sniezyna Watras-Gans, Sara Acker, Olga Poznansky, Ken Cullen, Yelena Itskovich, and Igor Galynker
[Abstract] [PDF]

920 Differential Effects of Risperidone, Olanzapine, Clozapine, and Conventional Antipsychotics on Type 2 Diabetes: Findings From a Large Health Plan Database. Frank D. Gianfrancesco, Amy L. Grogg, Ramy A. Mahmoud, Ruey-hua Wang, and Henry A. Nasrallah
[Abstract] [PDF]

931 Olanzapine in Refractory Schizophrenia After Failure of Typical or Atypical Antipsychotic Treatment: An Open-Label Switch Study. Jean-Pierre Lindenmayer, Pal Czobor, Jan Volavka, Jeffrey A. Lieberman, Leslie Citrome, Brian Sheitman, Miranda Chakos, and Joseph P. McEvoy
[Abstract] [PDF]

936 Risk Factors for Falls During Treatment of Late-Life Depression. Jin H. Joo, Eric J. Lenze, Benoit H. Mulsant, Amy E. Begley, Elizabeth M. Weber, Jacqueline A. Stack, Sati Mazumdar, Charles F. Reynolds III, and Bruce G. Pollock
[Abstract] [PDF]

942 Is Response to Prophylactic Lithium a Familial Trait? Paul Grof, Anne Duffy, Patrizia Cavazzoni, Eva Grof, Julie Garnham, Marsha MacDougall, Claire O'Donovan, and Martin Alda
[Abstract] [PDF]

Letters To the Editor

948 Severe Hypertriglyceridemia Associated With Olanzapine. Steven C. Stoner, Beth M. Dubisar, Rintu Khan, and Cynthia D. Farrar
[PDF]

949 Nicotine-Induced Angiogenesis. Michael Alan Schwartz
[PDF]

  • Reply by R. Douglas Shytle, Archie A. Silver, and Paul R. Sanberg

Book Reviews 951

NOW @ Psychiatrist.com 956

Information for Authors

see July 2002, pages 591-593 or our Web site at www.psychiatrist.com/author.htm